Arcutis Biotherapeutics (NASDAQ: ARQT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Arcutis Biotherapeutics (NASDAQ: ARQT) through any online brokerage.
The latest price target for Arcutis Biotherapeutics (NASDAQ: ARQT) was reported by Morgan Stanley on Tuesday, August 2, 2022. The analyst firm set a price target for 45.00 expecting ARQT to rise to within 12 months (a possible 84.05% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $24.45 last updated Today at August 8, 2022, 3:56 PM UTC.
There are no upcoming dividends for Arcutis Biotherapeutics.
Arcutis Biotherapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Arcutis Biotherapeutics.
Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.